Ezetimibe/rosuvastatin
< Ezetimibe
Ezetimibe (top) and rosuvastatin (bottom) | |
| Combination of | |
|---|---|
| Ezetimibe | Hypolipidemic agent |
| Rosuvastatin | Statin |
| Clinical data | |
| Trade names | Ridutrink, Roszet, others |
| AHFS/Drugs.com | Multum Consumer Information |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| KEGG | |
Ezetimibe/rosuvastatin, sold under the brand name Ridutrin among others, is a combination medication used to treat high cholesterol. In some countries it is sold as a kit or a pack containing two distinct pills.
The combination was approved for medical use in the United States in March 2021.